Literature DB >> 33972774

Characteristics of expedited programmes for cancer drug approval in China.

Guanqiao Li, Yang Liu, Cuicui Xie, Qing Zhou, Xiaoyuan Chen.   

Abstract

Entities:  

Year:  2021        PMID： 33972774     DOI： 10.1038/d41573-021-00080-0

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

Review 1.  Availability and Affordability of Oncology Drugs in 2012-2021 in China and the United States.

Authors:  Huiyao Huang; Qi Zhu; Man Ga; Dawei Wu; Xinyu Meng; Shuhang Wang; Hong Fang; Yu Tang; Ning Li
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

2.  Cigarette smoke exposed airway epithelial cell-derived EVs promote pro-inflammatory macrophage activation in alpha-1 antitrypsin deficiency.

Authors:  Nazli Khodayari; Regina Oshins; Borna Mehrad; Jorge E Lascano; Xiao Qiang; Jesse R West; L Shannon Holliday; Jungnam Lee; Gayle Wiesemann; Soroush Eydgahi; Mark Brantly
Journal:  Respir Res       Date:  2022-09-06

3.  Overall Survival Benefits of Cancer Drugs Approved in China From 2005 to 2020.

Authors:  Yichen Zhang; Huseyin Naci; Anita K Wagner; Ziyue Xu; Yu Yang; Jun Zhu; Jiafu Ji; Luwen Shi; Xiaodong Guan
Journal:  JAMA Netw Open       Date:  2022-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.